The optimum balance between efficacy and toxicity with different doses of trastuzumab deruxtecan in HER2 mutated non-small cell lung cancer in DESTINY-Lung02 trial
@article{ACTR9769,
author = {Saurav Verma and Jacques Raphael},
title = {The optimum balance between efficacy and toxicity with different doses of trastuzumab deruxtecan in HER2 mutated non-small cell lung cancer in DESTINY-Lung02 trial},
journal = {AME Clinical Trials Review},
volume = {2},
number = {0},
year = {2024},
keywords = {},
abstract = {},
issn = {3005-6152}, url = {https://actr.amegroups.org/article/view/9769}
}